Xu Cheryl
Förmögenhet: 5 891 $ per 2026-05-31
Förmögenhet: 5 891 $ per 2026-05-31
Xu Cheryl is currently Director at 60 Degrees Pharmaceuticals, Inc. since 2023.
Former positions include Director-International Finance at Pharmacia Corp.
and Vice President-Public Policy & Government Affairs at Biogen, Inc. Education includes an MBA from the University of Washington and an undergraduate degree from Peking University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-07-02 | 3 954 ( 0,15 % ) | 5 891 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| 60 DEGREES PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2023-07-12 |
| Företag | Position | Slut |
|---|---|---|
| BIOGEN INC. | Företagsledare/Principal | 2023-03-01 |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Finansdirektör/CFO | 2013-03-28 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for infectious diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån